1. Home
  2. WSBF vs OBIO Comparison

WSBF vs OBIO Comparison

Compare WSBF & OBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Waterstone Financial Inc. (MD)

WSBF

Waterstone Financial Inc. (MD)

HOLD

Current Price

$19.83

Market Cap

360.8M

Sector

Finance

ML Signal

HOLD

Logo Orchestra BioMed Holdings Inc.

OBIO

Orchestra BioMed Holdings Inc.

HOLD

Current Price

$5.58

Market Cap

362.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WSBF
OBIO
Founded
1921
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
360.8M
362.4M
IPO Year
2013
2020

Fundamental Metrics

Financial Performance
Metric
WSBF
OBIO
Price
$19.83
$5.58
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
★ $12.43
AVG Volume (30 Days)
55.3K
★ 295.8K
Earning Date
11-03-2026
11-09-2026
Dividend Yield
★ 3.39%
N/A
EPS Growth
★ 46.53
33.13
EPS
★ 0.84
N/A
Revenue
N/A
★ $33,482,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$8.67
$33.03
P/E Ratio
$23.83
★ N/A
Revenue Growth
N/A
★ 1169.22
52 Week Low
$15.05
$3.46
52 Week High
$21.66
$6.50

Technical Indicators

Market Signals
Indicator
WSBF
OBIO
Relative Strength Index (RSI) 49.00 46.17
Support Level $19.09 $5.54
Resistance Level $21.33 $5.78
Average True Range (ATR) 0.43 0.34
MACD 0.07 -0.06
Stochastic Oscillator 69.91 22.50

Price Performance

Historical Comparison
WSBF
OBIO

About WSBF Waterstone Financial Inc. (MD)

Waterstone Financial Inc is a holding company. Through its subsidiaries, it operates in two reportable segments: Community Banking and Mortgage Banking. The Community Banking segment provides consumer and business banking products and services to customers, which include various types of loans, deposits, and personal investment services. The Mortgage Banking segment involves residential mortgage loans for the primary purpose of sale in the secondary market. The majority of its revenue comes from the Community Banking segment.

About OBIO Orchestra BioMed Holdings Inc.

Orchestra BioMed Holdings Inc is a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships with medical device companies. The company's flagship product candidates are Atrioventricular Interval Modulation Therapy (AVIM Therapy) for the treatment of hypertension, the risk factor for death, and Virtue Sirolimus AngioInfusion Balloon (Virtue SAB) for the treatment of atherosclerotic artery disease, the cause of mortality. It has one reportable segment, which consists of the development of clinical and preclinical product candidates through risk-reward sharing partnerships with medical device companies.

Share on Social Networks: